Towercrest Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,163
| Closed | -$1.33M | – | 106 |
|
|
2024
Q3 | $1.33M | Hold |
9,163
| – | – | 0.22% | 47 |
|
|
2024
Q2 | $1.26M | Sell |
9,163
-5,450
| -37% | -$748K | 0.21% | 47 |
|
|
2024
Q1 | $2.01M | Sell |
14,613
-5
| -0% | -$686 | 0.34% | 43 |
|
|
2023
Q4 | $1.99M | Hold |
14,618
| – | – | 0.36% | 43 |
|
|
2023
Q3 | $1.79M | Sell |
14,618
-3,260
| -18% | -$399K | 0.35% | 45 |
|
|
2023
Q2 | $2.27M | Hold |
17,878
| – | – | 0.42% | 41 |
|
|
2023
Q1 | $2.31M | Hold |
17,878
| – | – | 0.48% | 38 |
|
|
2022
Q4 | $2.35M | Sell |
17,878
-427
| -2% | -$56.1K | 0.52% | 37 |
|
|
2022
Q3 | $2.14M | Hold |
18,305
| – | – | 0.5% | 38 |
|
|
2022
Q2 | $2.15M | Hold |
18,305
| – | – | 0.48% | 36 |
|
|
2022
Q1 | $2.39M | Hold |
18,305
| – | – | 0.47% | 38 |
|
|
2021
Q4 | $2.79M | Hold |
18,305
| – | – | 0.51% | 35 |
|
|
2021
Q3 | $2.96M | Hold |
18,305
| – | – | 0.56% | 35 |
|
|
2021
Q2 | $3M | Buy |
18,305
+3,687
| +25% | +$603K | 0.58% | 34 |
|
|
2021
Q1 | $2.2M | Hold |
14,618
| – | – | 0.47% | 35 |
|
|
2020
Q4 | $2.21M | Hold |
14,618
| – | – | 0.5% | 36 |
|
|
2020
Q3 | $1.98M | Hold |
14,618
| – | – | 0.49% | 35 |
|
|
2020
Q2 | $2M | Sell |
14,618
-1,000
| -6% | -$137K | 0.52% | 35 |
|
|
2020
Q1 | $1.68M | Buy |
15,618
+1,000
| +7% | +$108K | 0.51% | 35 |
|
|
2019
Q4 | $1.76M | Sell |
14,618
-500
| -3% | -$60.3K | 0.45% | 37 |
|
|
2019
Q3 | $1.5M | Hold |
15,118
| – | – | 0.42% | 37 |
|
|
2019
Q2 | $1.65M | Sell |
15,118
-1,499
| -9% | -$164K | 0.47% | 36 |
|
|
2019
Q1 | $1.86M | Sell |
16,617
-4,746
| -22% | -$530K | 0.54% | 34 |
|
|
2018
Q4 | $2.06M | Buy |
21,363
+6,500
| +44% | +$627K | 0.66% | 35 |
|
|
2018
Q3 | $1.81M | Buy |
+14,863
| New | +$1.81M | 0.54% | 39 |
|